Background: Biochemical recurrence (BCR) occurs in 20-40% of men after radical prostatectomy. Existing postoperative recurrence risk tools based on PSA and pathology are clinically useful but show only moderate and variable discrimination, highlighting the need for biomarkers that improve risk stratification and conseq...
B. Wang, S. Mukherjee, A. Baj et al.· medRxiv· 0 citations
Background and Objectives: Multiparametric MRI (mpMRI) has improved the detection of clinically significant prostate cancer (csPCa). However, the diagnostic utility of mpMRI is heavily dependent on image quality, which is often inconsistent across clinical settings. We investigated the association between mpMRI quality...
Donald C. Wunsch, O. Esengur, R. Makwana et al.· European Journal of Radiolog...· 0 citations
This prospective single-center study examined whether prostate-specific antigen (PSA)-based measures could identify a low-risk subgroup suitable for biopsy deferral in patients with Prostate Imaging-Reporting and Data System (PI-RADS) 1-3 lesions, and which clinical & imaging factors further refined risk stratification...
O. Esengur, S. Harmon, Emma J. Stevenson et al.· The Prostate· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.